DR. ALEXANDRA P IKEGUCHI M.D.
Prescription History 1962402321
Internal Medicine - Hematology & Oncology in Seattle, WA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ALEXANDRA P IKEGUCHI M.D., an active Hematology & Oncology specialist practicing in Seattle, WA. Our medical registry currently tracks 12 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 236 documented patient claims. Among these therapy options, the most frequently utilized medication is Ondansetron Hcl, which accounts for 35 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other WA PrescribersVs. WA Avg |
|---|---|---|---|
| Ondansetron Hcl | 35 | $7.83▼ below WA avg | ≈ Typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 35 Medicare prescriptions for Ondansetron Hcl, about 1.2 times the volume of the typical Washington prescriber of this medication (29). Medicare paid an average of $7.83 per fill, versus $11.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 35 30-Day Fills standardized to 30-day supplies 590 Days of Medication total across all patients in 2024 | |||
| Anastrozole | 29 | $26.21 | ▼ Less than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 29 Medicare prescriptions for Anastrozole, about half the volume of the typical Washington prescriber of this medication (63.7). Medicare paid an average of $26.21 per fill, versus $17.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63 30-Day Fills standardized to 30-day supplies 1,890 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 28 | $16,242.48▼ below WA avg | ≈ Typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 28 Medicare prescriptions for Imbruvica, about 1.2 times the volume of the typical Washington prescriber of this medication (24.3). Medicare paid an average of $16,242.48 per fill, versus $16,282.74 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 28 30-Day Fills standardized to 30-day supplies 784 Days of Medication total across all patients in 2024 | |||
| Prednisone | 27 | $5.68 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 27 Medicare prescriptions for Prednisone, about 71% of the volume of the typical Washington prescriber of this medication (38). Medicare paid an average of $5.68 per fill, versus $5.30 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 688 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 23 | $29.94 | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 23 Medicare prescriptions for Oxycodone Hcl, about half the volume of the typical Washington prescriber of this medication (50.3). Medicare paid an average of $29.94 per fill, versus $14.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 628 Days of Medication total across all patients in 2024 | |||
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $34.34 | ▼ Less than typical |
About Hydrocodone-Acetaminophen: This combination medication is used to relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2024, this provider wrote 21 Medicare prescriptions for Hydrocodone-Acetaminophen, about a third of the volume of the typical Washington prescriber of this medication (60.4). Medicare paid an average of $34.34 per fill, versus $20.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 586 Days of Medication total across all patients in 2024 | |||
| IbrancePalbociclib | 13 | $14,676.08▼ below WA avg | ▼ Less than typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6. In 2024, this provider wrote 13 Medicare prescriptions for Ibrance, about 63% of the volume of the typical Washington prescriber of this medication (20.6). Medicare paid an average of $14,676.08 per fill, versus $15,767.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2024 | |||
| Letrozole | 13 | $24.61 | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 13 Medicare prescriptions for Letrozole, about a quarter of the volume of the typical Washington prescriber of this medication (50.4). Medicare paid an average of $24.61 per fill, versus $22.98 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 860 Days of Medication total across all patients in 2024 | |||
| ScemblixAsciminib Hydrochloride | 13 | $21,924.24 | – No State Data |
About Scemblix: Asciminib is used to treat a certain type of cancer (chronic myeloid leukemia-CML). Show more ▾ Asciminib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Inhibits ABL1 protein. In 2024, this provider wrote 13 Medicare prescriptions for Scemblix. Medicare paid an average of $21,924.24 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $21,924.24 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2024 | |||
| Hydromorphone Hcl | 12 | $17.74▼ below WA avg | ▼ Less than typical |
About Hydromorphone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Hydromorphone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. An opioid analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine. In 2024, this provider wrote 12 Medicare prescriptions for Hydromorphone Hcl, about a third of the volume of the typical Washington prescriber of this medication (30.3). Medicare paid an average of $17.74 per fill, versus $18.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 12 30-Day Fills standardized to 30-day supplies 335 Days of Medication total across all patients in 2024 | |||
| Hydrocortisone | 11 | $28.60 | ▼ Less than typical |
About Hydrocortisone: This medication is used to treat a variety of skin conditions (such as insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Show more ▾ Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2024, this provider wrote 11 Medicare prescriptions for Hydrocortisone, about a third of the volume of the typical Washington prescriber of this medication (28.4). Medicare paid an average of $28.60 per fill, versus $19.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 328 Days of Medication total across all patients in 2024 | |||
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $61.12 | ▼ Less than typical |
About Oxycodone-Acetaminophen: This combination medication is used to help relieve moderate to severe pain. Show more ▾ It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. In 2024, this provider wrote 11 Medicare prescriptions for Oxycodone-Acetaminophen, about a quarter of the volume of the typical Washington prescriber of this medication (40.8). Medicare paid an average of $61.12 per fill, versus $25.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. ALEXANDRA P IKEGUCHI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Seattle, WA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among WA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
